November 18th, 2013
Surgery is thought to be life-saving for people who have ischemic mitral regurgitation, but it is unknown whether surgical repair or surgical replacement of the mitral valve is the better procedure. Repair is thought to result in fewer preoperative deaths and replacement is thought to have better long-term outcomes with a reduced incidence of recurrent […]
October 25th, 2013
The FDA today approved Abbott’s catheter-based MitraClip device for patients with significant symptomatic degenerative MR who are at prohibitive risk for mitral valve surgery. The company said it would launch the device immediately in the United States. The device is the first percutaneous nonsurgical therapy approved for the treatment of mitral valve disease. Surgery remains the option […]
September 6th, 2013
Rakesh M. Suri and Maurice Enriquez-Sarano discuss their research group’s comparison of early mitral valve surgery with initial medical management among patients in the Mitral Regurgitation International Database.
June 11th, 2012
A new study of mortality and other trends among Medicare patients who undergo mitral valve surgery may influence whom you choose to refer for this type of procedure.
April 8th, 2011
CardioExchange welcomes Ted Feldman, lead investigator for the EVEREST II study published earlier this week in the NEJM and presented at the ACC Scientific Sessions in New Orleans. Drs. Richard A. Lange and L. David Hillis, of CardioExchange, asked Dr. Feldman about the nuances of this randomized trial, in which percutaneous repair was compared with […]